202 related articles for article (PubMed ID: 27340027)
1. [Management of neuroendocrine prostate carcinoma: Literature review].
Yossi S; Brahmi T; Enachescu C; Selmaji I; Lapierre A; Samlali H; Chapet O
Cancer Radiother; 2016 Jun; 20(4):330-5. PubMed ID: 27340027
[TBL] [Abstract][Full Text] [Related]
2. [Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature].
Bellefqih S; Khalil J; Mezouri I; Kebdani T; Benjaafar N
Cancer Radiother; 2014 Jun; 18(3):201-7. PubMed ID: 24656987
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives.
Helpap B; Köllermann J; Oehler U
Urol Int; 1999; 62(3):133-8. PubMed ID: 10529661
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing?
Slovin SF
Nat Clin Pract Urol; 2006 Mar; 3(3):138-44. PubMed ID: 16528286
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge.
Helpap B; Klöppel G
Virchows Arch; 2002 Mar; 440(3):241-8. PubMed ID: 11889593
[TBL] [Abstract][Full Text] [Related]
6. [Small cell neuroendocrine carcinoma of the bladder: Report of five cases and a review of the literature].
Safini F; Jouhadi H; Marnissi F; Bouchbika Z; Benchakroun N; Tawfiq N; Sahraoui S; Benider A
Cancer Radiother; 2018 Sep; 22(5):417-422. PubMed ID: 30049597
[TBL] [Abstract][Full Text] [Related]
7. [Neuroendocrine tumors of the prostate].
Bours AF; Jorion JL; Donnay M; Ledent G; Van Ruyssevelt C
Acta Urol Belg; 1993 Sep; 61(3):13-6. PubMed ID: 8256680
[TBL] [Abstract][Full Text] [Related]
8. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
Helpap B
Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
[TBL] [Abstract][Full Text] [Related]
9. Large-cell neuroendocrine carcinoma of prostate. Case report.
Moratalla Charcos LM; Pastor Navarro T; Cortes Vizcaino V; Osca Garcia JM; Gil Salom M
Arch Esp Urol; 2013 May; 66(4):368-71. PubMed ID: 23676541
[TBL] [Abstract][Full Text] [Related]
10. Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.
Tu X; Chang T; Nie L; Qiu S; Xu H; Huang Y; Bao Y; Liu Z; Yang L; Wei Q
Urol Int; 2019; 103(4):383-390. PubMed ID: 30965328
[TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine carcinoma of the digestive tract: a literature review].
Jacob J; Chargari C; Helissey C; Ferrand FR; Ceccaldi B; Le Moulec S; Bauduceau O; Fayolle M; Védrine L
Rev Med Interne; 2013 Nov; 34(11):700-5. PubMed ID: 23871177
[TBL] [Abstract][Full Text] [Related]
12. How phenotype guides management of the neuroendocrine carcinomas of the larynx.
López F; Hunt JL; Nixon IJ; Rinaldo A; Williams MD; Cardesa A; Ferlito A
J Laryngol Otol; 2018 Jul; 132(7):568-574. PubMed ID: 29909787
[TBL] [Abstract][Full Text] [Related]
13. [Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review].
Feki J; Fourati N; Mnif H; Khabir A; Toumi N; Khanfir A; Boudawara T; Amouri H; Daoud J; Frikha M
Cancer Radiother; 2015 Aug; 19(5):308-12. PubMed ID: 26215367
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].
Pellat A; Wislez M; Svrcek M; Hammel P; Afchain P; André T
Bull Cancer; 2016 Oct; 103(10):880-895. PubMed ID: 27507031
[TBL] [Abstract][Full Text] [Related]
15. Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature.
Sleiman W; Karray O; Abi Abdallah M; Bleichner-Perez S; Kourda J; Cosma-Opris M; Assouad S; Riffaud JC; Bart S; Coloby P
J Med Case Rep; 2021 May; 15(1):254. PubMed ID: 33957979
[TBL] [Abstract][Full Text] [Related]
16. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported cases.
van der Laan TP; Plaat BE; van der Laan BF; Halmos GB
Head Neck; 2015 May; 37(5):707-15. PubMed ID: 24596175
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.
Priemer DS; Montironi R; Wang L; Williamson SR; Lopez-Beltran A; Cheng L
Endocr Pathol; 2016 Jun; 27(2):123-35. PubMed ID: 26885643
[TBL] [Abstract][Full Text] [Related]
18. Mixed primary prostatic carcinoma with acinar, neuroendocrine and ductal components.
Romero-Rojas AE; Diaz-Perez JA; Reddy A
Arch Ital Urol Androl; 2014 Jun; 86(2):150-1. PubMed ID: 25017603
[TBL] [Abstract][Full Text] [Related]
19. [Neuroendocrine carcinoma of the bladder: A single centre retrospective study].
Ayedi I; Abdelli I; Chaabouni H; Charfi S; Khanfir A; Toumi N; Mhiri N; Daoud J; Frikha M
Cancer Radiother; 2016 Feb; 20(1):1-5. PubMed ID: 26762704
[TBL] [Abstract][Full Text] [Related]
20. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]